Description
Overview
Retatrutide is a next-generation synthetic peptide engineered as a triple receptor agonist, designed as a research model for investigating coordinated GLP-1, GIP and glucagon receptor signalling within a single molecular framework.
By integrating three complementary metabolic receptor systems into one engineered peptide, Retatrutide provides researchers with a unique model for exploring receptor cross-talk, endocrine communication and multi-target peptide design.
AMINOSPX supplies Retatrutide exclusively for legitimate laboratory, analytical, scientific and in-vitro research purposes.
Not intended for human consumption or for medical, therapeutic, diagnostic, veterinary, cosmetic or food use.
Reviews
There are no reviews yet.